6714 related articles for article (PubMed ID: 2242781)
21. A mild form of xeroderma pigmentosum assigned to complementation group G and its repair heterogeneity.
Ichihashi M; Fujiwara Y; Uehara Y; Matsumoto A
J Invest Dermatol; 1985 Sep; 85(3):284-7. PubMed ID: 4031543
[TBL] [Abstract][Full Text] [Related]
22. Xeroderma pigmentosum variant associated with multiple cancers.
Kuwamoto K; Miyauchi-Hashimoto H; Isei T; Horio T
Photodermatol Photoimmunol Photomed; 1999; 15(3-4):127-32. PubMed ID: 10404723
[TBL] [Abstract][Full Text] [Related]
23. Report of three sisters with XP-E, a rare xeroderma pigmentosum complementation group.
Fischer E; Schnyder UW; Jung EG
Photodermatol; 1984 Oct; 1(5):232-6. PubMed ID: 6531300
[TBL] [Abstract][Full Text] [Related]
24. Basosquamous carcinoma and melanoma collision tumor in a child with xeroderma pigmentosum.
Bostanci S; Akay BN; Kirmizi A; Okcu Heper A; Farabi B
Pediatr Dermatol; 2020 Mar; 37(2):390-392. PubMed ID: 31957124
[TBL] [Abstract][Full Text] [Related]
25. Xeroderma pigmentosum variant associated with multiple skin cancers and a lung cancer.
Mamada A; Miura K; Tsunoda K; Hirose I; Furuya M; Kondo S
Dermatology; 1992; 184(3):177-81. PubMed ID: 1392108
[TBL] [Abstract][Full Text] [Related]
26. Sodium butyrate stimulates cellular recovery from UV damage in xeroderma pigmentosum cells belonging to complementation group F.
Nishigori C; Takebe H
Jpn J Cancer Res; 1987 Sep; 78(9):932-6. PubMed ID: 3117749
[TBL] [Abstract][Full Text] [Related]
27. A 10-year follow-up of a child with mild case of xeroderma pigmentosum complementation group D diagnosed by whole-genome sequencing.
Ono R; Masaki T; Mayca Pozo F; Nakazawa Y; Swagemakers SM; Nakano E; Sakai W; Takeuchi S; Kanda F; Ogi T; van der Spek PJ; Sugasawa K; Nishigori C
Photodermatol Photoimmunol Photomed; 2016 Jul; 32(4):174-80. PubMed ID: 26993158
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneity of xeroderma pigmentosum (XP); variability and stability within and between the complementation groups C, D, E, I and variants.
Jung EG; Bohnert E; Fischer E
Photodermatol; 1986 Jun; 3(3):125-32. PubMed ID: 3748852
[TBL] [Abstract][Full Text] [Related]
29. Xeroderma pigmentosum and squamous cell carcinoma of the tongue. Identification of two black patients as members of complementation group C.
Wade MH; Plotnick H
J Am Acad Dermatol; 1985 Mar; 12(3):515-21. PubMed ID: 3989010
[TBL] [Abstract][Full Text] [Related]
30. Melanoma and other skin cancers in xeroderma pigmentosum patients and mutation in their cells.
Takebe H; Nishigori C; Tatsumi K
J Invest Dermatol; 1989 May; 92(5 Suppl):236S-238S. PubMed ID: 2715657
[TBL] [Abstract][Full Text] [Related]
31. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
[TBL] [Abstract][Full Text] [Related]
32. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
[TBL] [Abstract][Full Text] [Related]
33. Assignment of a Chinese xeroderma pigmentosum patient from Taiwan to complementation group C.
Wang Y; Kobayashi K; Chang HR; Zeng Y; Ishizaki K; Dai H; Kuan YZ; Ikenaga M
J Radiat Res; 1991 Jun; 32(2):181-90. PubMed ID: 1941768
[TBL] [Abstract][Full Text] [Related]
34. Somatic mosaicism for DNA repair capacity in fibroblasts derived from a group A xeroderma pigmentosum patient.
Chang HR; Ishizaki K; Sasaki MS; Toguchida J; Kato M; Nakamura Y; Kawamura S; Moriguchi T; Ikenaga M
J Invest Dermatol; 1989 Oct; 93(4):460-5. PubMed ID: 2570806
[TBL] [Abstract][Full Text] [Related]
35. Precursor lesion of malignant melanoma in xeroderma pigmentosum: reflections about solar lentigo as the precursor.
Hedblad MA; Borglund E
J Am Acad Dermatol; 1995 Apr; 32(4):680-2. PubMed ID: 7755744
[No Abstract] [Full Text] [Related]
36. Establishment and characterization of a melanoma cell line from a xeroderma pigmentosum patient: activation of N-ras at a potential pyrimidine dimer site.
Keijzer W; Mulder MP; Langeveld JC; Smit EM; Bos JL; Bootsma D; Hoeijmakers JH
Cancer Res; 1989 Mar; 49(5):1229-35. PubMed ID: 2645048
[TBL] [Abstract][Full Text] [Related]
37. DNA repair characteristics and skin cancers of xeroderma pigmentosum patients in Japan.
Takebe H; Miki Y; Kozuka T; Furuyama JI; Tanaka K
Cancer Res; 1977 Feb; 37(2):490-5. PubMed ID: 832273
[TBL] [Abstract][Full Text] [Related]
38. A case of xeroderma pigmentosum complementation group C with diverse clinical features.
Masaki T; Nakano E; Okamura K; Ono R; Sugasawa K; Lee MH; Suzuki T; Nishigori C
Br J Dermatol; 2018 Jun; 178(6):1451-1452. PubMed ID: 29330851
[No Abstract] [Full Text] [Related]
39. Xeroderma pigmentosum complementation group G--report of two cases.
Norris PG; Hawk JL; Avery JA; Giannelli F
Br J Dermatol; 1987 Jun; 116(6):861-6. PubMed ID: 3620347
[TBL] [Abstract][Full Text] [Related]
40. Correlation of phenotype/genotype in a cohort of 23 xeroderma pigmentosum-variant patients reveals 12 new disease-causing POLH mutations.
Opletalova K; Bourillon A; Yang W; Pouvelle C; Armier J; Despras E; Ludovic M; Mateus C; Robert C; Kannouche P; Soufir N; Sarasin A
Hum Mutat; 2014 Jan; 35(1):117-28. PubMed ID: 24130121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
